← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap — 3,138 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
PCYO
PURE CYCLE CORP
Deeply overvalued
Utilities
Price$11.11
Model IV$4.42
P/IV2.34
Premium +151% Return to IV: -60.2%
PDC
Perpetuals.com Ltd
Valuation N/A
Technology
Price$3.25
Model IV—
P/IV—
Market implies +42.3%/yr
PDCC
Pearl Diver Credit Co Inc.
Valuation N/A
Unknown
Price$7.95
Model IV—
P/IV—
Limited data — see page
PDEX
PRO DEX INC
Deeply overvalued
Healthcare
Price$62.49
Model IV$44.41
P/IV1.46
Premium +41% Return to IV: -28.9%
Market implies -0.6%/yr vs model +15.0% · below model
PDO
PIMCO Dynamic Income Opportunities Fund
Valuation N/A
Unknown
Price$12.10
Model IV—
P/IV—
Limited data — see page
PDPA
Pearl Diver Credit Co Inc.
Valuation N/A
Unknown
Price$24.98
Model IV—
P/IV—
Limited data — see page
PDSB
PDS Biotechnology Corp
Valuation N/A
Healthcare
Price$1.38
Model IV—
P/IV—
Limited data — see page
PDT
JOHN HANCOCK PREMIUM DIVIDEND FUND
Valuation N/A
Unknown
Price$12.04
Model IV—
P/IV—
Limited data — see page
PDX
PIMCO Dynamic Income Strategy Fund
Valuation N/A
Unknown
Price$20.83
Model IV—
P/IV—
Limited data — see page
PDYN
Palladyne AI Corp.
Valuation N/A
Technology
Price$5.04
Model IV—
P/IV—
Market implies +74.8%/yr
PDYNW
Palladyne AI Corp.
Valuation N/A
Technology
Price$0.00
Model IV—
P/IV—
Market implies -50.0%/yr
PEBK
PEOPLES BANCORP OF NORTH CAROLINA INC
Deeply overvalued
Financial Services
Price$43.78
Model IV$32.87
P/IV1.28
Premium +33% Return to IV: -24.9%
PED
PEDEVCO CORP
Deeply undervalued
Energy
Price$13.47
Model IV$20.64
P/IV0.64
Discount 35% Return to IV: +53.2%
Market implies -2.7%/yr vs model +7.5% · below model
PEO
ADAMS NATURAL RESOURCES FUND, INC.
Valuation N/A
Unknown
Price$28.86
Model IV—
P/IV—
Limited data — see page
PEPG
PepGen Inc.
Valuation N/A
Healthcare
Price$2.62
Model IV—
P/IV—
Limited data — see page
PERF
Perfect Corp.
Fairly valued
Technology
Price$1.92
Model IV$1.79
P/IV1.07
Premium +7% Return to IV: -6.6%
Market implies +8.8%/yr vs model +12.6% · below model
PESI
PERMA FIX ENVIRONMENTAL SERVICES INC
Valuation N/A
Utilities
Price$13.76
Model IV—
P/IV—
Limited data — see page
PETS
PETMED EXPRESS INC
Deeply undervalued
Consumer Cyclical
Price$1.29
Model IV$4.95
P/IV0.44
Discount 74% Return to IV: +285.2%
Market implies -28.1%/yr vs model +2.0% · below model
PETZ
TDH Holdings, Inc.
Valuation N/A
Real Estate
Price$1.26
Model IV—
P/IV—
Market implies +26.2%/yr vs model +3.7% · above model
PEW
GrabAGun Digital Holdings Inc.
Undervalued
Consumer Cyclical
Price$1.86
Model IV$2.61
P/IV0.83
Discount 29% Return to IV: +40.3%
Market implies -6.3%/yr vs model +15.0% · below model
PFAI
Pinnacle Food Group Ltd
Valuation N/A
Basic Materials
Price$3.05
Model IV—
P/IV—
Market implies +57.0%/yr vs model +8.0% · above model
PFBC
Preferred Bank
Valuation N/A
Unknown
Price$102.58
Model IV—
P/IV—
Limited data — see page
PFD
FLAHERTY & CRUMRINE PREFERRED & INCOME FUND INC
Valuation N/A
Unknown
Price$10.58
Model IV—
P/IV—
Limited data — see page
PFL
PIMCO INCOME STRATEGY FUND
Valuation N/A
Unknown
Price$6.94
Model IV—
P/IV—
Limited data — see page
PFN
PIMCO Income Strategy Fund II
Valuation N/A
Unknown
Price$6.25
Model IV—
P/IV—
Limited data — see page
PFO
Flaherty & Crumrine PREFERRED & INCOME OPPORTUNITY FUND INC
Valuation N/A
Unknown
Price$8.56
Model IV—
P/IV—
Limited data — see page
PFSA
Profusa, Inc.
Valuation N/A
Healthcare
Price$1.42
Model IV—
P/IV—
Market implies +16.2%/yr
PFX
PhenixFIN Corp
Valuation N/A
Unknown
Price$44.95
Model IV—
P/IV—
Limited data — see page
PFXNZ
PhenixFIN Corp
Valuation N/A
Unknown
Price$24.07
Model IV—
P/IV—
Limited data — see page
PGAC
PANTAGES CAPITAL ACQUISITION Corp
Valuation N/A
Financial Services
Price$10.77
Model IV—
P/IV—
Limited data — see page
PGACR
PANTAGES CAPITAL ACQUISITION Corp
Valuation N/A
Financial Services
Price$0.19
Model IV—
P/IV—
Limited data — see page
PGACU
PANTAGES CAPITAL ACQUISITION Corp
Valuation N/A
Financial Services
Price$10.89
Model IV—
P/IV—
Limited data — see page
PGP
PIMCO Global StocksPLUS & Income Fund
Valuation N/A
Unknown
Price$8.25
Model IV—
P/IV—
Limited data — see page
PGZ
Principal Real Estate Income Fund
Valuation N/A
Unknown
Price$8.90
Model IV—
P/IV—
Limited data — see page
PHGE
BiomX Inc.
Valuation N/A
Healthcare
Price$0.29
Model IV—
P/IV—
Limited data — see page
PHIO
Phio Pharmaceuticals Corp.
Valuation N/A
Healthcare
Price$0.98
Model IV—
P/IV—
Limited data — see page
PHK
PIMCO HIGH INCOME FUND
Valuation N/A
Unknown
Price$4.16
Model IV—
P/IV—
Limited data — see page
PHUN
Phunware, Inc.
Valuation N/A
Technology
Price$2.11
Model IV—
P/IV—
Market implies +77.3%/yr vs model +2.0% · above model
PIII
P3 Health Partners Inc.
Valuation N/A
Healthcare
Price$4.95
Model IV—
P/IV—
Market implies -50.0%/yr vs model +26.0% · below model
PIIIW
P3 Health Partners Inc.
Valuation N/A
Healthcare
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr vs model +26.0% · below model
PINE
Alpine Income Property Trust, Inc.
Deeply overvalued
Financial Services
Price$17.92
Model IV$11.42
P/IV1.48
Premium +57% Return to IV: -36.3%
PJT
PJT Partners Inc.
Valuation N/A
Financial Services
Price$137.28
Model IV—
P/IV—
Limited data — see page
PLAG
Planet Green Holdings Corp.
Valuation N/A
Consumer Defensive
Price$0.71
Model IV—
P/IV—
Market implies +27.7%/yr vs model +2.0% · above model
PLBY
Playboy, Inc.
Deeply overvalued
Consumer Cyclical
Price$0.98
Model IV$0.53
P/IV2.60
Premium +86% Return to IV: -46.4%
Market implies +8.0%/yr vs model +2.0% · above model
PLCE
Childrens Place, Inc.
Valuation N/A
Consumer Cyclical
Price$1.42
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
PLG
PLATINUM GROUP METALS LTD
Valuation N/A
Basic Materials
Price$1.29
Model IV—
P/IV—
Market implies +46.7%/yr vs model +5.0% · above model
PLMK
Plum Acquisition Corp, IV
Valuation N/A
Financial Services
Price$10.64
Model IV—
P/IV—
Limited data — see page
PLMKU
Plum Acquisition Corp, IV
Valuation N/A
Utilities
Price$10.76
Model IV—
P/IV—
Limited data — see page
PLMKW
Plum Acquisition Corp, IV
Valuation N/A
Utilities
Price$0.40
Model IV—
P/IV—
Limited data — see page
PLRX
PLIANT THERAPEUTICS, INC.
Valuation N/A
Healthcare
Price$1.02
Model IV—
P/IV—
Market implies +46.3%/yr vs model +15.0% · above model
PLRZ
Polyrizon Ltd.
Valuation N/A
Healthcare
Price$8.99
Model IV—
P/IV—
Limited data — see page
PLSM
Pulsenmore Ltd.
Valuation N/A
Healthcare
Price$1.85
Model IV—
P/IV—
Limited data — see page
PLTM
GraniteShares Platinum Trust
Valuation N/A
Financial Services
Price$16.18
Model IV—
P/IV—
Limited data — see page
PLTS
Platinum Analytics Cayman Ltd
Valuation N/A
Technology
Price$17.50
Model IV—
P/IV—
Market implies +31.2%/yr
PLUR
Pluri Inc.
Valuation N/A
Healthcare
Price$0.95
Model IV—
P/IV—
Market implies +12.5%/yr vs model +15.0% · in line
PLUT
Plutus Financial Group Ltd
Valuation N/A
Financial Services
Price$2.07
Model IV—
P/IV—
Market implies +31.8%/yr
PLX
Protalix BioTherapeutics, Inc.
Valuation N/A
Healthcare
Price$2.78
Model IV—
P/IV—
Market implies +18.3%/yr
PLYX
Polaryx Therapeutics, Inc.
Valuation N/A
Healthcare
Price$2.00
Model IV—
P/IV—
Limited data — see page
PMAX
Powell Max Ltd
Deeply overvalued
Technology
Price$0.69
Model IV$0.20
P/IV4.51
Premium +241% Return to IV: -70.6%
Market implies +20.7%/yr vs model +15.0% · above model
PMCB
PharmaCyte Biotech, Inc.
Valuation N/A
Healthcare
Price$0.40
Model IV—
P/IV—
Limited data — see page